Sophia S. Chen

Array ( [id] => 6477503 [patent_doc_number] => 20100285055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Activation of natural killer (NK) cells and methods of use' [patent_app_type] => utility [patent_app_number] => 12/661636 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16224 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285055.pdf [firstpage_image] =>[orig_patent_app_number] => 12661636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454891 [patent_doc_number] => 20100189742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines' [patent_app_type] => utility [patent_app_number] => 12/592528 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20845 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189742.pdf [firstpage_image] =>[orig_patent_app_number] => 12592528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10844055 [patent_doc_number] => 08871226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-28 [patent_title] => 'Methods and compositions for the treatment and diagnosis of cancer' [patent_app_type] => utility [patent_app_number] => 12/689658 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 9230 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12689658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908986 [patent_doc_number] => 08481045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Immunogenic protein constructs' [patent_app_type] => utility [patent_app_number] => 12/687653 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13309 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12687653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582287 [patent_doc_number] => 20100129901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'HEPATITIS C VIRUS VACCINE' [patent_app_type] => utility [patent_app_number] => 12/633104 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 22342 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12633104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431182 [patent_doc_number] => 20100143378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Subcutaneous Administration of Anti-Hepatitis B Antibodies' [patent_app_type] => utility [patent_app_number] => 12/630433 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11240 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143378.pdf [firstpage_image] =>[orig_patent_app_number] => 12630433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425832 [patent_doc_number] => 20100151492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS' [patent_app_type] => utility [patent_app_number] => 12/626848 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 67282 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151492.pdf [firstpage_image] =>[orig_patent_app_number] => 12626848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500238 [patent_doc_number] => 20100215662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Anti-influenza M2e antibody' [patent_app_type] => utility [patent_app_number] => 12/592241 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16098 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215662.pdf [firstpage_image] =>[orig_patent_app_number] => 12592241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8683932 [patent_doc_number] => 20130052215 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-02-28 [patent_title] => 'TUMOR VACCINE' [patent_app_type] => utility [patent_app_number] => 12/580554 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18680 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10505288 [patent_doc_number] => 09233148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza' [patent_app_type] => utility [patent_app_number] => 12/581112 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 53076 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12581112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8683932 [patent_doc_number] => 20130052215 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-02-28 [patent_title] => 'TUMOR VACCINE' [patent_app_type] => utility [patent_app_number] => 12/580554 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18680 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783923 [patent_doc_number] => 20120045479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'Dry Powder Formulations, Vaccines and Methods' [patent_app_type] => utility [patent_app_number] => 13/124701 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4146 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045479.pdf [firstpage_image] =>[orig_patent_app_number] => 13124701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372567 [patent_doc_number] => 20100080775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'RECOMBINANT ADENOVIRUSES ENCODING THE SPECIFIC IODINE TRANSPORTER (NIS)' [patent_app_type] => utility [patent_app_number] => 12/567076 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9825 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080775.pdf [firstpage_image] =>[orig_patent_app_number] => 12567076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479077 [patent_doc_number] => 20100285132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'IMMUNOTHERAPY COMPOSITIONS, METHOD OF MAKING AND METHOD OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/562432 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 17275 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285132.pdf [firstpage_image] =>[orig_patent_app_number] => 12562432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174704 [patent_doc_number] => 20110177163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A' [patent_app_type] => utility [patent_app_number] => 13/119583 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7386 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177163.pdf [firstpage_image] =>[orig_patent_app_number] => 13119583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372802 [patent_doc_number] => 20100080817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'HUMAN PAPILLOMAVIRUS / Ii-KEY HYBRIDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/552064 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8290 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080817.pdf [firstpage_image] =>[orig_patent_app_number] => 12552064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087929 [patent_doc_number] => 20110217307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'SYNTHETIC PEPTIDES CORRESPONDING TO OVERLAPPING NEUTRALIZING DETERMINANTS IN THE CBD1 EPITOPE INDUCE BROADLY NEUTRALIZING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/061035 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 35342 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217307.pdf [firstpage_image] =>[orig_patent_app_number] => 13061035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397352 [patent_doc_number] => 20090317415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'HPV VACCINE COMPRISING PEPTIDES FROM HOST CELL PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/538382 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12258 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317415.pdf [firstpage_image] =>[orig_patent_app_number] => 12538382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575080 [patent_doc_number] => 20100129389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'METHODS OF MODULATING HVEM, BTLA AND CD160 CIS COMPLEX RESPONSE OR SIGNALING ACTIVITY WITH SOLUBLE LIGHT POLYPEPTIDE SEQUENCES' [patent_app_type] => utility [patent_app_number] => 12/534658 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 25276 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129389.pdf [firstpage_image] =>[orig_patent_app_number] => 12534658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6347612 [patent_doc_number] => 20100330650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'RECOMBINANT VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS [JEV] INFECTION AND A METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/497217 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10336 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330650.pdf [firstpage_image] =>[orig_patent_app_number] => 12497217 [rel_patent_id] =>[rel_patent_doc_number] =>)